News

August 13, 2018

Antimalarial Medication Can Reduce Inflammation in SLE Patients, Study Shows

News

Hydroxychloroquine, an antimalarial medication, can help normalize levels of an immune molecule that promotes inflammation in patients with systemic lupus erythematosus, a study shows. The study, “Efficacy analysis of hydroxychloroquine ... Read more

August 10, 2018August 10, 2018

Virgin Olive Oil May Help Reduce SLE Activity, Mouse Study Suggests

News

Virgin olive oil, especially its phenol components, showed anti-inflammatory properties in mice with systemic lupus erythematosus (SLE) and in human immune cells, according to a new Spanish study. The findings ... Read more

August 8, 2018

Infection Is Leading Cause of Death in Lupus Patients in China, Study Finds

News

In China, mortality rates are higher among women with systemic lupus erythematosus (SLE) than men, with infection being the leading cause of death, a study reports. According to the ... Read more

August 6, 2018

Lupus Patients Show Signs of Heart Problems at Diagnosis, Study Finds

News

At the time of diagnosis, systemic lupus erythematosus (SLE) patients already show signs of heart impairment, even before any symptoms of chest discomfort, a new imaging study shows. The findings indicate ... Read more

August 3, 2018August 3, 2018

UV Light Sensitivity in Lupus Patients Linked to Interferon Produced by Skin Cells

News

Interferon-kappa (IFN-κ), an immune response regulator, is a key mediator of skin lesions and UV light sensitivity in cutaneous lupus erythematosus patients, a study reports. Its researchers suggest that ... Read more

August 1, 2018August 6, 2018

Lupus Clinical Trials May Not Be Representative of Real-World Population, Report Suggests

News

Patients participating in Phase 3 clinical trials testing new therapies for systemic lupus erythematosus (SLE) are not necessarily representative of real-world patient populations, according to a new report. Even if the ... Read more

July 30, 2018July 30, 2018

SLE Patients’ Perception of Doctors Also Influences Adherence to Medication, Researchers Say

News

Skepticism as to whether physicians or other providers should determine one’s health, along with the perception that a medicine is harmful or addictive, help to explain why patients with ... Read more

July 27, 2018July 27, 2018

Rheumatoid Arthritis Medicine Seen to Ease Lupus Symptoms at Higher Dose in Phase 2 Trial

News

Baricitinib — a medicine approved in the U.S., Europe, and Japan for rheumatoid arthritis — can significantly improve symptoms of systemic lupus erythematosus (SLE), the treatment’s maker, Eli Lilly, and its partner Incyte announced. This ... Read more

July 25, 2018July 25, 2018

Human T-cells Reprogrammed for Therapeutic Purposes with CRISPR-Cas9, Researchers Say

News

A team of scientists from the University of California San Francisco has developed an innovative technique to genetically engineer genes involved in the body’s immune response. This new approach has the potential ... Read more

July 23, 2018July 25, 2018

US Congress Earmarks Millions for Lupus Research and Education in 2019 Spending Bills

News

The U.S. House of Representatives has approved a bill that includes $5 million in funding for the Lupus Research Program at the Department of Defense in 2019. Approval comes ... Read more

This is a short description about myself and what this site is about. I hope you enjoy being here!

News

Antimalarial Medication Can Reduce Inflammation in SLE Patients, Study Shows

Virgin Olive Oil May Help Reduce SLE Activity, Mouse Study Suggests

Infection Is Leading Cause of Death in Lupus Patients in China, Study Finds

Lupus Patients Show Signs of Heart Problems at Diagnosis, Study Finds

UV Light Sensitivity in Lupus Patients Linked to Interferon Produced by Skin Cells

Lupus Clinical Trials May Not Be Representative of Real-World Population, Report Suggests

SLE Patients’ Perception of Doctors Also Influences Adherence to Medication, Researchers Say

Rheumatoid Arthritis Medicine Seen to Ease Lupus Symptoms at Higher Dose in Phase 2 Trial

Human T-cells Reprogrammed for Therapeutic Purposes with CRISPR-Cas9, Researchers Say

US Congress Earmarks Millions for Lupus Research and Education in 2019 Spending Bills

Pin It on Pinterest